Skip to main content

AI Suggestions and Prescribing: Where Clinical Review Must Control the Workflow

An AI suggestion should not become an active diagnosis, prescription or patient instruction merely because generated text appeared or was inserted into a note. Keep the proposed content distinguishable from the authorised clinical decision, expose its basis and let the responsible clinician review the exact order. Evaluate each automation by what it can change and who can authorise that change.

By Bractis · Updated · 9 min read

Indian doctors and clinic owners evaluating AI assistance, clinical decision support and prescription automation in outpatient software.

Distinguish assistance, calculation and clinical authorisation

“AI prescribing” can describe very different products: a dictation tool that copies a medicine name, a calculator, a rule-based warning, a suggested order set or a system that selects treatment. Grouping these together hides the decision the clinic actually needs to make.

Start by identifying what the feature changes. Does it propose text, populate an editable draft, modify a structured field, create an order or issue instructions to a patient? The consequences grow when output moves from something a clinician can inspect to something another person may act on.

WHO warns that generated systems can produce inaccurate information and encourage automation bias. This supports careful scrutiny of suggestions, but it does not mean every calculator or clinical algorithm has the same failure mechanism. The evaluation should match the actual feature and intended use.

This article proposes a clinician-controlled workflow for outpatient software. It does not claim that every form of medical automation is universally prohibited by one law, or that a review button alone establishes safe practice.

Source: WHO: AI ethics and governance guidance, 18 January 2024

Locate the exact transition from proposal to actionable order

Draw the pathway from input to output and name the actor at each transition. A suggestion can become actionable in several places: an order list, a printed prescription, a pharmacy queue or a patient message. Reviewing only the note editor can miss the most consequential step.

Define what the clinician’s action authorises. Approving a paragraph of history should not silently create a medicine order. Selecting a catalogue match should not imply agreement with a suggested dose, duration or indication that was never displayed.

The original table below separates levels of effect. It is an evaluation aid, not a regulatory classification of medical devices.

On a narrow screen, scroll the table horizontally to read all columns.

The risk question changes when software can act on a suggestion
Feature effectReview needed for that effectUnacceptable inference to avoid
Draft narrativeCompare meaning with the encounter and sourceFluent wording proves the assessment occurred
CalculationVerify inputs, units, method and applicabilityA computed number is automatically the correct treatment
Suggested diagnosis or orderAssess basis, uncertainty and patient-specific relevanceA recommendation is already a clinician decision
Structured record changeConfirm the exact field, status, source and downstream useInserting text approves every related field
Issued prescription or instructionAuthorise the exact final content through the proper workflowGenerating or previewing a document is sufficient sign-off

Give the clinician enough information to assess the suggestion

A proposed order needs an inspectable basis appropriate to its purpose. That may include the source facts, relevant rules or evidence, missing information and the system’s intended scope. A polished explanation generated by the same model is not independent proof that the recommendation is correct.

Check the patient inputs that materially affect the decision. A stale medicine list, wrong encounter, uncertain allergy history or unit mismatch can make a technically consistent suggestion inappropriate. The clinician should be able to inspect and correct those inputs before authorising the action.

Keep missing data visible. A system should not fill a required measurement with a typical value or convert an unknown condition into a negative finding simply to complete a recommendation. A complete-looking input set can be less trustworthy than an honest unresolved one.

Where the tool uses a deterministic calculation, distinguish input verification from method verification. A correct formula applied to the wrong units is still wrong. The clinic’s assessment should address the calculation’s intended population and use through appropriate clinical expertise, not just whether the arithmetic runs.

Make review possible in the time and context available

A nominal clinician approval can become a formality if the proposed order is hidden, the alternatives are unclear or a busy workflow rewards accepting defaults. Display the complete actionable content and allow correction or rejection without forcing the user through an unrelated task.

Review should cover the actual version that will be issued. If the software regenerates instructions after approval, the final content may differ from what the clinician saw. Test changes to medicine selection, strength, directions and destination after the draft review.

The SAFER order-entry guidance includes design, implementation and monitoring of clinical decision support. In this article, that becomes a practical requirement to inspect the whole ordering workflow rather than rely on a broad “doctor in control” claim.

Record what the clinician did without claiming more than the event proves. An acceptance event identifies an action; it does not certify the clinical judgment. Preserve appropriate accountability and a route for later correction without describing the software as transferring responsibility automatically.

Source: ASTP/ONC: SAFER Computerized Provider Order Entry with Decision Support

Test boundary cases that expose unintended authority

Use a fictional history saying that a patient previously stopped a medicine. Ask whether the feature merely drafts that history or creates a new active order. The expected result should be defined by the actual clinician decision, not by the presence of the medicine name in the input.

Use a fictional ambiguous product name or missing unit. The feature should expose the uncertainty through its supported process rather than choose a clinically specific answer to complete the form. The test is about preserving uncertainty, not about asking an assistant to recommend a substitute.

Test an unreviewed suggestion followed by printing, sharing and pharmacy handover. Confirm that a downstream output cannot acquire apparent authorisation simply because staff used another screen. A draft label inside the editor is insufficient if the printed copy looks final.

Finally, test a changed patient, changed source or late response after sign-off. The system should not reuse an earlier approval for different content. These cases are original acceptance tests and do not amount to a complete clinical validation study.

Record the decision boundary and the evidence supporting adoption

Procurement evidence should state the feature’s intended use, what it can modify, the authorising role and the limitations found. Separate demonstration results from vendor statements and from clinical validation evidence supplied for the product.

If the clinic limits a feature to drafting, confirm that configuration across roles and outputs. A restricted clinician view may still leave an administrative route that issues a proposed instruction. Review the actual permissions rather than the name of a setting.

The outline below makes the decision reviewable without pretending to replace specialist evaluation or applicable regulatory requirements.

Monitor real workflow effects after a limited rollout

If the feature is adopted after appropriate review, begin within the agreed scope and observe how clinicians use it. Look for acceptance without inspection, repeated corrections, unsupported field changes and outputs that reach patients before review. Do not equate a high acceptance rate with quality.

Review near misses and rejected suggestions as well as final records. A feature that is frequently corrected may still have value, but its total burden and error patterns need to be understood. A low complaint count alone cannot establish that the workflow is reliable.

Reassess when the model, prompt, catalogue, rule set or clinical form changes. A previous evaluation applies to a defined configuration and use case; it is not permanent approval of every future release.

The useful buying question is what the software can cause to happen without a meaningful clinician decision. Make that boundary visible, test it with fictional cases and obtain the professional evidence appropriate to the feature before using it in care.

Worked example: a stopped medicine becomes a fresh prescription

A fictional test note says that the patient reports having stopped an earlier medicine. A generation feature recognises the medicine name and adds it to the current order draft. The clinician rejects the proposal, but the test continues through print and sharing to check that no active instruction remains elsewhere. This exposes a change in intent from reported history to prescribing. Correct spelling would not have caught the problem; the important issue is what action the system created.

AI-to-Order Authority and Acceptance Review

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Effect inventory
List every field, order, document and message the feature can change. Which changes require a distinct authorising action?
Evidence access
For a fictional suggestion, identify the source facts, missing inputs and method or evidence available to the clinician.
Final-content check
Compare the reviewed proposal with the exact printed or shared instruction. Can regeneration or another role change it after approval?
Adoption scope
Separate observed behaviour, vendor claims and clinical validation. Record the configured limits and the owner of future review.

Questions doctors ask

Are transcription, calculators and autonomous treatment selection the same thing?

No. They have different inputs, purposes and effects. Evaluate what the feature can change and how the resulting action is authorised. A drafting aid and a treatment-selection system should not be accepted on the basis of the same demonstration.

Does adding a clinician approval button make an AI order safe?

Not by itself. The clinician needs the relevant basis, missing information and exact actionable content, with a usable way to correct or reject it. The approval must apply to the version actually issued and must not silently approve unrelated fields.

Can a generated diagnosis be treated as confirmed because it sounds plausible?

No. Plausible wording is not clinical evidence. The responsible clinician assesses the patient and the basis of the statement, preserves uncertainty where appropriate and determines what belongs in the authorised record.

Is a high AI suggestion acceptance rate a quality measure?

It describes use, not necessarily correctness or benefit. Examine meaningful review, corrections, rejected suggestions, downstream effects and missed problems. A high rate can coexist with default acceptance or automation bias.

What should an Indian clinic ask before enabling AI prescription suggestions?

Ask about intended scope, input reliability, what the feature can modify, authorisation, validation evidence and change monitoring. Use fictional boundary cases and inspect the complete patient-output route, with appropriate clinical and regulatory review for the actual product.

Sources and scope

Updated on . Workflow and procurement analysis, not a treatment recommendation or a universal legal classification of AI products. Clinical decisions and applicable product requirements need qualified review. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Ask Bractis to show exactly what its AI-assisted features can and cannot change. Use fictional history, missing-input and draft-to-print cases, and verify the authorisation boundary for the demonstrated configuration.

Request a clinic demo